H.Res. 1438 · 111th Congress
Promoting increased awareness and diagnosis of peripheral arterial disease (PAD) to address the high…
Full title
Promoting increased awareness and diagnosis of peripheral arterial disease (PAD) to address the high mortality rate of this treatable disease.
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 111th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
R
PaulsenSponsor1 cosponsor · 1 R
0 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
Declares that the House of Representatives: (1) identifies the need for actions to improve the diagnosis and treatment of peripheral arterial disease (PAD); and (2) resolves to promote efforts to increase public and clinician awareness of PAD.
What it does: CRS summary · Introduced in House · Jun 14, 2010
Declares that the House of Representatives: (1) identifies the need for actions to improve the diagnosis and treatment of peripheral arterial disease (PAD); and (2) resolves to promote efforts to increase public and clinician awareness of PAD.
Encourages: (1) the Administrator of the Center for Medicare and Medicaid Services to examine ways to increase the number of persons that are aware of and screened for PAD; and (2) the Director of the Centers for Disease Control and Prevention (CDC), acting through the National Heart Disease and Stroke Prevention Program, to examine ways to educate medical professionals about the benefits of PAD screening and assess and reduce regional disparities in the diagnosis and treatment of PAD.
Calls for the Director of the National Institutes of Health (NIH) to continue NIH's leadership role in the fight against PAD by: (1) continuing and increasing the support of its respective Institutes for basic and clinical PAD research, for PAD comparative effectiveness studies, and for assessing and improving public awareness of PAD; (2) encouraging the funding for biomedical research and education with respect to PAD through the co-sponsorship of workshops and seminars with respected patient organizations; (3) exploring collaborative opportunities for PAD research using the multidisciplinary approach; and (4) exploring collaborative opportunities with the Food and Drug Administration (FDA) and Centers for Medicare and Medicaid Services to expand access to proven diagnostic methods and therapeutic interventions via sponsorship of annual PAD strategic planning meetings.
Calls for the Agency of Healthcare Research and Quality to include PAD in its strategic vision to improve health outcomes, strengthen quality measurement and improvement, and improve health care access for individuals with PAD, through offering support to research centers that specialize in PAD health care research.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Promoting increased awareness and diagnosis of peripheral arterial disease (PAD) to address the high mortality rate of this treatable disease.
Latest action (Jun 14, 2010): Referred to the House Committee on Energy and Commerce.
Policy area: Health · Origin: House · Introduced: Jun 14, 2010
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.